Tongyu Zhu to China
This is a "connection" page, showing publications Tongyu Zhu has written about China.
Connection Strength
0.084
-
COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020 06 08; 11(6):438.
Score: 0.031
-
Epidemiology and clinical course of COVID-19 in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1537-1545.
Score: 0.008
-
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362.
Score: 0.008
-
Identifying the Risk of SARS-CoV-2 Infection and Environmental Monitoring in Airborne Infectious Isolation Rooms (AIIRs). Virol Sin. 2020 Dec; 35(6):785-792.
Score: 0.008
-
CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020; 10(12):5613-5622.
Score: 0.008
-
Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 05; 80(5):e1-e6.
Score: 0.008
-
Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation. J Diabetes. 2019 May; 11(5):370-378.
Score: 0.007
-
Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation. J Diabetes. 2018 Nov; 10(11):857-865.
Score: 0.007